drugset / Trial / NCT01250561

Reduction of Postherpetic Neuralgia in Herpes Zoster

NCT01250561

Completed 133 enrolled Center for Clinical Studies, Texas
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The addition of gabapentin therapy to standard antiviral treatment with valacyclovir in acute herpes zoster patients will decrease the incidence of post-herpetic neuralgia.

Timeline

Start
2002-02
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 3600 mg
Background Valacyclovir Unknown 1000 mg